Company Overview
- Headquarters
- 1275 W Washington St Ste 104, Tempe AZ
- Website
- capstonethx.com
- Phone
- (602) 286-5520
- Employees
- 8
- Founded in
- 2008
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 5417 CompaniesNAICS Code 541711 CompaniesNAICS Code 32541 CompaniesNAICS Code 541 CompaniesNAICS Code 3254 CompaniesNAICS Code 54 CompaniesNAICS Code 32 CompaniesNAICS Code 325 CompaniesNAICS Code 54171 CompaniesNAICS Code 325414 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$2B
Who is Capstone Therapeutics
Capstone Therapeutics, headquartered in Tempe, Arizona, is a clinical stage biotechnology company. Employing 8 individuals, Capstone Therapeutics generates approximately $2 million in annual revenue. Capstone Therapeutics focuses on developing novel peptide drugs aimed at treating cardiovascular patients struggling with elevated cholesterol and triglyceride levels. Their therapies target patients whose conditions are not effectively managed by conventional treatments. Their lead molecule, AEM-28, holds an FDA Orphan drug designation for Homozygous Familial Hypercholesterolemia (HoFH) and shows potential for applications in acute coronary syndrome, peripheral artery disease, and type 2 diabetes. Visit Capstone Therapeutics online at capstonethx.com.
Capstone Therapeutics Industry Tags
Capstone Therapeutics Tech Stack
Companies Similar to Capstone Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Capstone Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 2M | 48 | Rockville, MD | 2002 | |
| 2M | 70 | San Diego, CA | 2008 | |
| 2M | 10 | 2018 | ||
| 2M | 8 | Las Vegas, NV | 1998 | |
| 2M | 6 | Gainesville, FL | 2005 |